Not directly. Insurance typically covers TMS under a Major Depressive Disorder (MDD) diagnosis. If symptoms qualify as MDD, coverage may apply. We help navigate this process.
Yes. We often pair qpTMS™ with qEEG, neurofeedback, and PnIR—all of which are safe, non-invasive therapies for pregnant patients.
Some patients see improvement in 2–3 weeks, while others may take longer. Progress is evaluated regularly to adapt the treatment plan.
Yes. While focused on depression, qpTMS™ can also regulate brain regions involved in anxiety, offering broader emotional support.
